
Home
Chapter Home
Jobs
Conferences
Fellowships
Books
Advertisement
Bladder
Metaplasia
Intestinal metaplasia
Reviewer: Rugvedita Parakh, M.D. (see Reviewers page)
Revised: 9 February 2013, last major update July 2010
Copyright: (c) 2003-2013, PathologyOutlines.com, Inc.
Definition
=========================================================================
● Replacement of urothelium by colonic mucosa or isolated / clusters of goblet cells in Brunn’s nests
● See also
cystitis cystica / glandularis
Terminology
=========================================================================
● Also called glandular metaplasia, colonic metaplasia or goblet cell metaplasia
Epidemiology
=========================================================================
● Identified in 71-90% of bladders at autopsy
● Incidence increases with age
Sites
=========================================================================
● Trigone is most commonly affected area
● Also seen in ureter and renal pelvis
● Affects the bladder mucosa, typically the lamina propria
(J Urol 1968;100:462,
J Urol 2006;175:1119)
● Mostly focal but occasionally diffuse
Etiology
=========================================================================
● Variation of normal anatomy
● Also due to chronic inflammation, ureteral reimplantation, neurogenic bladder, bladder exstrophy
(J Urol 1981;126:822,
J Urol 1987;137:764),
paraplegia, stones, long term catheterization
Clinical features
=========================================================================
● Incidental finding or associated with hematuria, mucosuria, dysuria, urgency or obstructive symptoms
● May be confused cystoscopically with carcinoma, particularly if mucin extravasation is present
Prognostic factors
=========================================================================
● Is it a precursor lesion for adenocarcinoma?
Yes:
● Five large series; associated with 10-42% of reported cases of adenocarcinoma
● If extensive, patient is at high risk for adenocarcinoma
(Cancer 1987;59:2086)
● Molecular findings support the hypothesis that intestinal metaplasia is a precursor lesion to and could be a marker in the development of adenocarcinoma of the urinary bladder
(Clin Cancer Res 2007;13:6232)
● Nuclear beta catenin positivity suggests the potential to progress to malignancy as the signaling mechanism is similar to Barrett’s esophagus
(J Urol 2003;170:1892)
No:
● Does not appear to increase risk of adenocarcinoma
(Urology 2008;71:915,
Urology 1997;50:427)
Case reports
=========================================================================
● Case arising in residual native bladder in association with intestinal metaplasia and dysplasia of bladder mucosa 17 years following gastrocystoplasty
(J Pediatr Urol 2010;6:525)
● Case arising in spina bifida patient
(Ann Diagn Pathol 2007;11:453)
Treatment
=========================================================================
● May regress completely if pathogenic factor is removed
Gross description
=========================================================================
● Irregular rounded focal elevations of mucosa
● Rarely polypoidal with mucinous extravasations
Micro description
=========================================================================
● Replacement of urothelium by colonic mucosa (tall columnar cells)
● Also goblet cells (single or aggregates) within Brunn’s nests, variable presence of Paneth cells
● May coexist with cystitis cystica or cystitis glandularis
● Mucin may be occasionally extravasated into the stroma
● No atypia, no involvement of muscularis propria
Micro images
=========================================================================
Cystitis glandularis with intestinal metaplasia and mucin extravasation
Fig 1: marked edema of mucosa
Fig 2: proliferation of glands in lamina propria
Fig 3: glands are lined by columnar epithelium with goblet cells and Paneth cells, with no signet ring cells, atypia or mitotic figures
Fig 4: focal mucin extravasation
![]() Cystitis glandularis intestinal type (intestinal metaplasia) |
|
Cytology description
=========================================================================
● Cuboidal, columnar and mucin secreting cells
● Intestinal-type goblet cells may be seen
● Bland cytologic features
● Rare mitoses
(Diagn Cytopathol 2008;36:181)
Positive stains
=========================================================================
● Mucin stains have variable positivity
● CDX2 (83%), CK20
(Mod Pathol 2006;19:1395)
● Neuroendocrine markers in neuroendocrine cells
(Histopathology 1990;16:365)
● Nuclear beta-catenin
Negative stains
=========================================================================
● CK7 (usually), HEP (100%)
● Note: in the urinary bladder, intestinal metaplasia and typical cystitis glandularis have sharply contrasting immunoprofiles despite similar morphology
(Mod Pathol 2006;19:1395)
Electron microscopy description
=========================================================================
Cystitis cystica:
● Lining cells: short microvilli on luminal surface
● Taller cells: numerous membrane-bound electron-dense secretory granules
(Br J Urol 1993;71:28)
Molecular / cytogenetics description
=========================================================================
● Associated with significant telomere shortening and cytogenetic abnormalities
(Clin Cancer Res 2007;13:6232)
Differential diagnosis
=========================================================================
● Adenocarcinoma-primary, metastatic or from renal pelvis / ureter:
infiltrative with extensive muscle invasion, anaplasia, mitotic figures and extensive mucinous pools
(Hum Pathol 1997;28:1152)
● Neobladder derived from intestine (normal epithelium): clinical history, villous atrophy, reactive atypia, lymphoid aggregates
● Urothelial carcinoma:
florid metaplastic changes can mimic urothelial carcinoma, particularly the nested variant
(Am J Surg Pathol 2003;27:1243)
End of Bladder > Metaplasia > Intestinal metaplasia
This information is intended for physicians and related personnel, who understand that medical information is often imperfect, and must be interpreted in the context of a patient's clinical data using reasonable medical judgment. This website should not be used as a substitute for the advice of a licensed physician.
All information on this website is protected by copyright of PathologyOutlines.com, Inc. Information from third parties may also be protected by copyright. Please contact us at copyrightPathOut@gmail.com
with any questions (click here for other
contact information).